Anzeige
Erschienen in:
13.12.2019 | Seltene Erkrankungen
Hereditäres Angioödem
Erschienen in: Pädiatrie & Pädologie | Ausgabe 1/2020
Einloggen, um Zugang zu erhaltenBitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Literatur
1.
Zurück zum Zitat Bork K, Barnstedt SE, Koch P, Traupe H (2000) Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356(9225):213–217CrossRef
Bork K, Barnstedt SE, Koch P, Traupe H (2000) Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356(9225):213–217CrossRef
2.
Zurück zum Zitat Germenis AE, Speletas M (2016) Genetics of hereditary Angioedema revisited. Clin Rev Allergy Immunol 51(2):170–182CrossRef
Germenis AE, Speletas M (2016) Genetics of hereditary Angioedema revisited. Clin Rev Allergy Immunol 51(2):170–182CrossRef
3.
Zurück zum Zitat Dewald G, Bork K (2006) Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 343(4):1286–1289CrossRef
Dewald G, Bork K (2006) Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 343(4):1286–1289CrossRef
4.
Zurück zum Zitat De Maat S, Hofman ZLM, Maas C (2018) Hereditary angioedema: the plasma contact system out of control. J Thromb Haemost 16(9):1674–1685CrossRef
De Maat S, Hofman ZLM, Maas C (2018) Hereditary angioedema: the plasma contact system out of control. J Thromb Haemost 16(9):1674–1685CrossRef
5.
Zurück zum Zitat Bork K, Wulff K, Steinmuller-Magin L, Braenne I, Staubach-Renz P, Witzke G et al (2018) Hereditary angioedema with a mutation in the plasminogen gene. Allergy 73(2):442–450CrossRef
Bork K, Wulff K, Steinmuller-Magin L, Braenne I, Staubach-Renz P, Witzke G et al (2018) Hereditary angioedema with a mutation in the plasminogen gene. Allergy 73(2):442–450CrossRef
6.
Zurück zum Zitat Bafunno V, Firinu D, D’Apolito M, Cordisco G, Loffredo S, Leccese A et al (2018) Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema. J Allergy Clin Immunol 141(3):1009–1017CrossRef
Bafunno V, Firinu D, D’Apolito M, Cordisco G, Loffredo S, Leccese A et al (2018) Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema. J Allergy Clin Immunol 141(3):1009–1017CrossRef
7.
Zurück zum Zitat Speletas M, Szilagyi A, Csuka D, Koutsostathis N, Psarros F, Moldovan D et al (2015) F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema. Allergy 70(12):1661–1664CrossRef
Speletas M, Szilagyi A, Csuka D, Koutsostathis N, Psarros F, Moldovan D et al (2015) F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema. Allergy 70(12):1661–1664CrossRef
8.
Zurück zum Zitat Gianni P, Loules G, Zamanakou M, Kompoti M, Csuka D, Psarros F et al (2017) Genetic determinants of C1 inhibitor deficiency angioedema age of onset. Int Arch Allergy Immunol 174(3–4):200–204CrossRef
Gianni P, Loules G, Zamanakou M, Kompoti M, Csuka D, Psarros F et al (2017) Genetic determinants of C1 inhibitor deficiency angioedema age of onset. Int Arch Allergy Immunol 174(3–4):200–204CrossRef
9.
Zurück zum Zitat Aygören-Pürsün E, Magerl M, Maetzel A, Maurer M (2018) Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies. Orphanet J Rare Dis 13(1):73CrossRef
Aygören-Pürsün E, Magerl M, Maetzel A, Maurer M (2018) Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies. Orphanet J Rare Dis 13(1):73CrossRef
10.
Zurück zum Zitat Simao F, Feener EP (2017) The effects of the contact activation system on hemorrhage. Front Med (lausanne) 4:121CrossRef
Simao F, Feener EP (2017) The effects of the contact activation system on hemorrhage. Front Med (lausanne) 4:121CrossRef
11.
Zurück zum Zitat de Maat S, Bjorkqvist J, Suffritti C, Wiesenekker CP, Nagtegaal W, Koekman A et al (2016) Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations. J Allergy Clin Immunol 138(5):1414–1423CrossRef
de Maat S, Bjorkqvist J, Suffritti C, Wiesenekker CP, Nagtegaal W, Koekman A et al (2016) Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations. J Allergy Clin Immunol 138(5):1414–1423CrossRef
12.
Zurück zum Zitat Zanichelli A, Magerl M, Longhurst HJ, Aberer W, Caballero T, Bouillet L et al (2018) Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey. Clin Transl Allergy 8:42CrossRef
Zanichelli A, Magerl M, Longhurst HJ, Aberer W, Caballero T, Bouillet L et al (2018) Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey. Clin Transl Allergy 8:42CrossRef
13.
Zurück zum Zitat Caballero T, Aygören-Pürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z et al (2014) The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe. Allergy Asthma Proc 35(1):47–53CrossRef
Caballero T, Aygören-Pürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z et al (2014) The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe. Allergy Asthma Proc 35(1):47–53CrossRef
14.
Zurück zum Zitat Bork K, Staubach P, Eckardt AJ, Hardt J (2006) Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 101(3):619–627CrossRef
Bork K, Staubach P, Eckardt AJ, Hardt J (2006) Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 101(3):619–627CrossRef
15.
Zurück zum Zitat Bork K, Hardt J, Witzke G (2012) Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol 130(3):692–697CrossRef
Bork K, Hardt J, Witzke G (2012) Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol 130(3):692–697CrossRef
16.
Zurück zum Zitat Aygören-Pürsün E, Martinez Saguer I, Kreuz W, Klingebiel T, Schwabe D (2013) Risk of angioedema following invasive or surgical procedures in HAE type I and II—the natural history. Allergy 68(8):1034–1039CrossRef
Aygören-Pürsün E, Martinez Saguer I, Kreuz W, Klingebiel T, Schwabe D (2013) Risk of angioedema following invasive or surgical procedures in HAE type I and II—the natural history. Allergy 68(8):1034–1039CrossRef
17.
Zurück zum Zitat Bork K, Hardt J, Staubach-Renz P, Witzke G (2011) Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(1):58–64CrossRef
Bork K, Hardt J, Staubach-Renz P, Witzke G (2011) Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(1):58–64CrossRef
18.
Zurück zum Zitat Aygören-Pürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, Boysen HB et al (2016) Estimation of EuroQol 5‑Dimensions health status utility values in hereditary angioedema. Patient Prefer Adherence 10:1699–1707CrossRef
Aygören-Pürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, Boysen HB et al (2016) Estimation of EuroQol 5‑Dimensions health status utility values in hereditary angioedema. Patient Prefer Adherence 10:1699–1707CrossRef
19.
Zurück zum Zitat Aygören-Pürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, Wait S et al (2014) Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. Orphanet J Rare Dis 9:99CrossRef
Aygören-Pürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, Wait S et al (2014) Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. Orphanet J Rare Dis 9:99CrossRef
20.
Zurück zum Zitat Bork K, Wulff K, Witzke G, Hardt J (2017) Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII). Allergy 72(2):320–324CrossRef
Bork K, Wulff K, Witzke G, Hardt J (2017) Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII). Allergy 72(2):320–324CrossRef
21.
Zurück zum Zitat Aygören-Pürsün E (2019) Hereditäre Angioödeme – Aktuelle und zukünftige Therapien. Allergologie 42(1):31–38CrossRef
Aygören-Pürsün E (2019) Hereditäre Angioödeme – Aktuelle und zukünftige Therapien. Allergologie 42(1):31–38CrossRef
22.
Zurück zum Zitat Maurer M, Aberer W, Bouillet L, Caballero T, Fabien V, Kanny G et al (2013) Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS ONE 8(2):e53773CrossRef
Maurer M, Aberer W, Bouillet L, Caballero T, Fabien V, Kanny G et al (2013) Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS ONE 8(2):e53773CrossRef
23.
Zurück zum Zitat Maurer M, Magerl M, Ansotegui I, Aygören-Pürsün E, Betschel S, Bork K et al (2018) The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update. Allergy 73(8):1575–1596CrossRef
Maurer M, Magerl M, Ansotegui I, Aygören-Pürsün E, Betschel S, Bork K et al (2018) The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update. Allergy 73(8):1575–1596CrossRef
24.
Zurück zum Zitat Bork K, Aygören-Pürsün E, Bas M, Biedermann T, Greve J, Hartmann K et al (2019) Guideline: Hereditary angioedema due to C1 inhibitor deficiency. Allergo J Int 28:16–29CrossRef
Bork K, Aygören-Pürsün E, Bas M, Biedermann T, Greve J, Hartmann K et al (2019) Guideline: Hereditary angioedema due to C1 inhibitor deficiency. Allergo J Int 28:16–29CrossRef
25.
Zurück zum Zitat Longhurst H, Cicardi M, Craig T, Bork K, Grattan C, Baker J et al (2017) Prevention of hereditary Angioedema attacks with a subcutaneous C1 inhibitor. N Engl J Med 376(12):1131–1140CrossRef
Longhurst H, Cicardi M, Craig T, Bork K, Grattan C, Baker J et al (2017) Prevention of hereditary Angioedema attacks with a subcutaneous C1 inhibitor. N Engl J Med 376(12):1131–1140CrossRef
26.
Zurück zum Zitat Banerji A, Riedl MA, Bernstein JA, Cicardi M, Longhurst HJ, Zuraw BL et al (2018) Effect of Lanadelumab compared with placebo on prevention of hereditary Angioedema attacks: a randomized clinical trial. JAMA 320(20):2108–2121CrossRef
Banerji A, Riedl MA, Bernstein JA, Cicardi M, Longhurst HJ, Zuraw BL et al (2018) Effect of Lanadelumab compared with placebo on prevention of hereditary Angioedema attacks: a randomized clinical trial. JAMA 320(20):2108–2121CrossRef
27.
Zurück zum Zitat Aygören-Pürsün E, Magerl M, Graff J, Martinez-Saguer I, Kreuz W, Longhurst H et al (2016) Prophylaxis of hereditary angioedema attacks: a randomized trial of oral plasma kallikrein inhibition with avoralstat. J Allergy Clin Immunol 138(3):934–936CrossRef
Aygören-Pürsün E, Magerl M, Graff J, Martinez-Saguer I, Kreuz W, Longhurst H et al (2016) Prophylaxis of hereditary angioedema attacks: a randomized trial of oral plasma kallikrein inhibition with avoralstat. J Allergy Clin Immunol 138(3):934–936CrossRef
28.
Zurück zum Zitat Riedl MA, Aygören-Pürsün E, Baker J, Farkas H, Anderson J, Bernstein JA et al (2018) Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study. Allergy 73(9):1871–1880CrossRef
Riedl MA, Aygören-Pürsün E, Baker J, Farkas H, Anderson J, Bernstein JA et al (2018) Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study. Allergy 73(9):1871–1880CrossRef
29.
Zurück zum Zitat Aygören-Pürsün E, Bygum A, Grivcheva-Panovska V, Magerl M, Graff J, Steiner UC et al (2018) Oral plasma Kallikrein inhibitor for prophylaxis in hereditary Angioedema. N Engl J Med 379(4):352–362CrossRef
Aygören-Pürsün E, Bygum A, Grivcheva-Panovska V, Magerl M, Graff J, Steiner UC et al (2018) Oral plasma Kallikrein inhibitor for prophylaxis in hereditary Angioedema. N Engl J Med 379(4):352–362CrossRef
30.
Zurück zum Zitat Worm M, Kohler EC, Panda R, Long A, Butler LM, Stavrou EX et al (2015) The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities. Ann Transl Med 3(17):247PubMedPubMedCentral
Worm M, Kohler EC, Panda R, Long A, Butler LM, Stavrou EX et al (2015) The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities. Ann Transl Med 3(17):247PubMedPubMedCentral
31.
Zurück zum Zitat Qiu T, Chiuchiolo MJ, Whaley AS, Russo AR, Sondhi D, Kaminsky SM et al (2018) Gene therapy for C1 Esterase inhibitor deficiency in a murine model of hereditary Angioedema. Allergy 74(6):1081–1089
Qiu T, Chiuchiolo MJ, Whaley AS, Russo AR, Sondhi D, Kaminsky SM et al (2018) Gene therapy for C1 Esterase inhibitor deficiency in a murine model of hereditary Angioedema. Allergy 74(6):1081–1089
Metadaten
- Titel
- Hereditäres Angioödem
- verfasst von
-
Dr. Emel Aygören-Pürsün
Univ.-Prof. Dr. Konrad Bork
- Publikationsdatum
- 13.12.2019
- Verlag
- Springer Vienna
- Erschienen in
-
Pädiatrie & Pädologie
/ Ausgabe 1/2020
Print ISSN: 0030-9338
Elektronische ISSN: 1613-7558 - DOI
- https://doi.org/10.1007/s00608-019-00738-4
